CLINICAL_TRIALS
trial_result
· 2014-12-25
Clinical Trial Update: BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction [Phase 4]
Summary
A Phase 4 randomized trial comparing BAY38-9456 at 5 mg and 10 mg to placebo for erectile dysfunction has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 4 | Status: COMPLETED